Natalizumab discontinuation in the increasing complexity of multiple sclerosis therapy
- PMID: 24682968
 - DOI: 10.1212/WNL.0000000000000369
 
Natalizumab discontinuation in the increasing complexity of multiple sclerosis therapy
Comment on
- 
  
  MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study.Neurology. 2014 Apr 29;82(17):1491-8. doi: 10.1212/WNL.0000000000000355. Epub 2014 Mar 28. Neurology. 2014. PMID: 24682966 Free PMC article. Clinical Trial.
 
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical